復星醫藥(600196.SH):控股子公司擬受讓ONCOCARE合計60%股權
格隆匯6月6日丨復星醫藥(600196.SH)公佈,2022年6月6日,公司控股子公司Fosun Pharma Pte.與 Solid Success(即“賣方一”)及其控股股東Aurora Healthcare 簽訂《Solid Success股權轉讓協議》,Fosun Pharma Pte.擬現金出資不超過1.85億新幣受讓賣方一持有的OncoCare51%的股權,賣方一之控股股東Aurora Healthcare擔保Solid Success在協議項下各項義務的履行。
同日,Fosun Pharma Pte.與SMS及3名持股醫生(即“賣方二”)簽訂《其他股東股權轉讓協議》,Fosun Pharma Pte.擬合計現金出資不超過3265.1萬新幣受讓賣方二持有的OncoCare9%的股權。
此次交易全部完成後,Fosun Pharma Pte.將持有OncoCare 60%的股權,OncoCare將納入集團合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.